This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Vertex Pharmaceuticals, Inc.. Active years: 2024.
Company Filing History:
Years Active: 2024
Title: Laura Sandler: Innovator in Hematopoietic Stem Cell Research
Introduction
Laura Sandler is a prominent inventor based in Cambridge, MA (US). She has made significant contributions to the field of hematopoietic stem cell research, particularly through her innovative work involving CRISPR technology. Her research focuses on developing treatments for genetic blood disorders, showcasing her commitment to advancing medical science.
Latest Patents
Laura Sandler holds a patent for "CRISPR-CAS9 modified CD34+ human hematopoietic stem and progenitor cells and uses thereof." This patent outlines methods and compositions for treating subjects with β-thalassemia and severe sickle cell disease using autologous CRISPR-Cas9 modified CD34+ human hematopoietic stem and progenitor cells. This groundbreaking work has the potential to transform the treatment landscape for these challenging conditions.
Career Highlights
Laura is currently employed at Vertex Pharmaceuticals, Inc., where she continues to push the boundaries of research in gene editing and stem cell therapy. Her work at Vertex has positioned her as a key player in the biotechnology industry, contributing to the development of innovative therapies that address unmet medical needs.
Collaborations
Throughout her career, Laura has collaborated with esteemed colleagues, including Tony Ho and Robert Carl Kauffman. These partnerships have fostered a collaborative environment that enhances the research and development of cutting-edge treatments.
Conclusion
Laura Sandler's contributions to the field of hematopoietic stem cell research and her innovative use of CRISPR technology highlight her as a leading inventor in the biotechnology sector. Her work not only advances scientific knowledge but also holds the promise of improving the lives of patients with genetic blood disorders.